��������

Dr. Lukas Pluska is a skilled professional with extensive experience in business development and scientific research. Currently serving as a Business Development Manager at Exazyme since February 2023, Pluska's previous role as a Consultant at Scitaris involved R&D strategy development for pharmaceutical and biotech companies, focusing on indications and assets evaluation, market dynamics, and technical pre-due diligence work. A postdoctoral research scientist at the Max Delbrück Center from December 2013 to September 2021, Pluska contributed to proteomics assay development and cell biology studies. With a doctorate in Biochemistry from Humboldt-Universität zu Berlin and a diploma from Freie Universität Berlin, Pluska's academic background includes significant research contributions across various esteemed institutions.